A preliminary risk prediction model for cannabis use disorder.

Barratt impulsivity scale questionnaire Extraversion Impulsive sensation-seeking scale questionnaire LASSO Neuroticism Openness inventory

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 02 07 2020
revised: 27 09 2020
accepted: 13 10 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 19 11 2020
Statut: epublish

Résumé

The ongoing trend toward legalization of cannabis for medicinal/recreational purposes is expected to increase the prevalence of cannabis use disorder (CUD). Thus, it is imperative to be able to predict the quantitative risk of developing CUD for a cannabis user based on their personal risk factors. Yet no such model currently exists. In this study, we perform preliminary analysis toward building such a model. The data come from n = 94 regular cannabis users recruited from Albuquerque, New Mexico during 2007-2010. As the data are cross-sectional, we only consider risk factors that remain relatively stable over time. We apply statistical and machine learning classification techniques that allow n to be small relative to the number of predictors. We use predictive accuracy estimated using leave-one-out-cross-validation to evaluate model performance. The final model is a LASSO logistic regression model consisting of the following seven risk factors: age; level of enjoyment from initial cigarette smoking; total score on Impulsive Sensation-Seeking Scale questionnaire; score on cognitive instability factor of Barratt Impulsivity Scale questionnaire; and scores on neuroticism, openness, and conscientiousness personality traits of Neuroticism, Extraversion, and Openness inventory. This model has an overall accuracy of 0.66 and the area under its receiver operating characteristic curve is 0.65. In summary, a preliminary relative risk model for predicting the quantitative risk of CUD is developed. It can be employed to identify users at high risk of CUD who may be provided with early intervention.

Identifiants

pubmed: 33204605
doi: 10.1016/j.pmedr.2020.101228
pii: S2211-3355(20)30186-8
pmc: PMC7649639
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101228

Informations de copyright

© 2020 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Arch Gen Psychiatry. 2008 Dec;65(12):1368-76
pubmed: 19047523
Psychol Med. 2016 Mar;46(4):877-89
pubmed: 26620720
Drug Alcohol Depend. 2014 Mar 1;136:51-62
pubmed: 24434016
Dev Psychopathol. 2018 May;30(2):417-435
pubmed: 28606210
Int J Clin Health Psychol. 2018 Sep-Dec;18(3):235-244
pubmed: 30487929
BMJ Open. 2016 Apr 05;6(4):e009986
pubmed: 27048634
JAMA Pediatr. 2014 Sep;168(9):822-8
pubmed: 25070067
Drug Alcohol Depend. 2008 Jan 1;92(1-3):239-47
pubmed: 17888588
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
J Natl Cancer Inst. 1989 Dec 20;81(24):1879-86
pubmed: 2593165
J Health Econ. 2015 Jul;42:64-80
pubmed: 25863001
IEEE J Biomed Health Inform. 2019 Sep;23(5):2196-2204
pubmed: 30507519
Addict Behav. 2015 Jun;45:113-8
pubmed: 25661989
J Child Psychol Psychiatry. 2018 Jun;59(6):618-627
pubmed: 28714184
Addict Behav. 2018 Apr;79:144-150
pubmed: 29289854
Breast Cancer Res Treat. 2018 Jul;170(2):415-423
pubmed: 29574637
J Addict Med. 2013 Mar-Apr;7(2):116-21
pubmed: 23370933
Psychiatry Res. 2016 Apr 30;238:356-362
pubmed: 27086256
Curr Behav Neurosci Rep. 2014 Mar 1;1(1):1-12
pubmed: 24772382
Clin Psychol Sci. 2016 Mar;4(2):167-182
pubmed: 27127730
J Addict Med. 2015 Nov-Dec;9(6):464-9
pubmed: 26441401
Psychol Addict Behav. 2017 Sep;31(6):664-675
pubmed: 28805408
J Clin Psychiatry. 2017 May;78(5):572-583
pubmed: 27337225
Brain Sci. 2020 Feb 27;10(3):
pubmed: 32120842
BMC Psychiatry. 2008 Apr 11;8:22
pubmed: 18405382
Am J Drug Alcohol Abuse. 2009;35(6):399-407
pubmed: 20014907
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Health Policy. 2018 Mar;122(3):205-209
pubmed: 29429644
Drug Alcohol Depend. 2019 Feb 1;195:13-15
pubmed: 30557813
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657-64
pubmed: 22927402
Drug Alcohol Depend. 2019 Jan 1;194:136-142
pubmed: 30439610
JAMA Psychiatry. 2017 Jun 1;74(6):579-588
pubmed: 28445557
Psychiatry Res. 2011 Mar 30;186(1):46-52
pubmed: 20813412
Int Rev Psychiatry. 2020 May;32(3):221-234
pubmed: 32026735
Psychopharmacology (Berl). 2013 Mar;226(2):307-19
pubmed: 23138434
Addiction. 2020 Aug;115(8):1411-1412
pubmed: 31746493
J Health Econ. 2014 Dec;38:43-61
pubmed: 25205609
JAMA Psychiatry. 2020 Feb 1;77(2):165-171
pubmed: 31722000
J Clin Psychol. 1995 Nov;51(6):768-74
pubmed: 8778124
Psychol Bull. 2010 Sep;136(5):768-821
pubmed: 20804236
Breast Cancer Res Treat. 2017 Jan;161(1):153-160
pubmed: 27815748
Addict Behav Rep. 2018 Jun 30;8:51-55
pubmed: 29992183
Subst Abuse Treat Prev Policy. 2015 Jun 10;10:23
pubmed: 26059021
Addiction. 1994 Mar;89(3):321-30
pubmed: 8173502
Nicotine Tob Res. 2011 Dec;13(12):1321-5
pubmed: 21849409
Behav Genet. 2009 May;39(3):233-44
pubmed: 19377872
Am J Drug Alcohol Abuse. 2013 Nov;39(6):382-91
pubmed: 24200208
Drug Alcohol Rev. 2020 Feb;39(2):142-151
pubmed: 31916333
Am J Drug Alcohol Abuse. 2014 Nov;40(6):463-75
pubmed: 25115831

Auteurs

Rajapaksha Mudalige Dhanushka S Rajapaksha (RMDS)

Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX, USA.

Ryan Hammonds (R)

School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX, USA.

Francesca Filbey (F)

School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX, USA.

Pankaj K Choudhary (PK)

Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX, USA.

Swati Biswas (S)

Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX, USA.

Classifications MeSH